Description

TheXTTCellProliferationAssay(XTT-CPA)isasensitivekitforthemeasurementofcellproliferation.Cleavageofthetetrazoliumsalttoformazanoccursviathesuccinate-tetrazoliumreductasesysteminthemitochondriaofmetabolicallyactivecells.

Features:

• Allowsmeasurementofcellproliferation,cellviABIlityorcytotoxicity.
• Rapiddeterminationinmicroplates(nosolubilizationstepasinanMTTassay).
• ReproducIBLeandsensitiveresults.
• NorADIoactivity.
• Idealforhighthroughputassays(nowashingorotherstepsthatcancausecelllossandvariability).

Catalog#4891-025-Kincludes:
CatalogNumber	Description	Qty
4891-025-01	XTTReagent	1
4891-025-02	XTTActivator	1

 

Akt-ActivatedEndotheliumConstitutestheNicheforResidualDiseaseandResistancetoBevacizumabinOvarianCancer
BellaS.Guerrouahen,JenniferPasquier,NadineAbuKaoud,MahtabMaleki,Marie-ClaudeBeauchamp,AmberYasmeen,PegahGhiabi,RaphaelLis,FabienVidal,AhmedSaleh,WalterH.Gotlieb,ShahinRafii,andArashRafii
Mol.CancerTher.,Dec2014;13:3123–3136.
http://mct.aacrjournals.org/cgi/content/abstract/13/12/3123

ASpliceVariantoftheHumanIonChannelTRPM2ModulatesNeuroblastomaTumorGrowththroughHypoxia-inducibleFactor(HIF)-1/2{alpha}
Shu-jenChen,NicholasE.Hoffman,SanthanamShanmughapriya,LeiBao,KerryKeefer,KathleenConrad,SalimMerali,YoshinoriTakahashi,ThomasAbraham,IwonaHirschler-Laszkiewicz,JuFangWang,Xue-QianZhang,JianliangSong,CarlosBarrero,YuguangShi,YukaImamuraKawasawa,MichaelBayerl,TianyuSun,MustafaBarbour,Hong-GangWang,MuniswamyMadesh,JosephY.Cheung,andBarbaraA.Miller
J.Biol.Chem.,Dec2014;289:36284–36302.
http://www.jbc.org/cgi/content/abstract/289/52/36284

“DepletionoftheHumanIonChannelTRPM2inNeuroblastoma
DemonstratesItsKeyRoleinCellSurvivalthroughModulationof
MitochondrialReactiveOxygenSpeciesandBioenergetics”
“LeiBao,Shu-jenChen,KathleenConrad,KerryKeefer,ThomasAbraham,JohnP.Lee,JuFangWang,Xue-QianZhang,IwonaHirschler-Laszkiewicz,Hong-GangWang,SinisaDovat,BrianGans,MuniswamyMadesh,JosephY.Cheung,andBarbaraA.Miller”
J.Biol.Chem.,Nov2016;291:24449–24464
http://www.jbc.org/cgi/content/abstract/291/47/24449

Trevigen，Inc.是一家发展迅速的生物技术公司，致力于开发用于癌症研究，药物发现，遗传毒理学，再生医学和干细胞研究的产品和技术。我们提供试剂盒和试剂，用于研究DNA损伤和修复，细胞凋亡，氧化应激，癌细胞行为，3D培养和干细胞。该公司获得了美国国立卫生研究院（National Institutes of Health）多项SBIR资助。